The authors describe a proprietary process for producing a stable, topical interferon alpha-2b formulation that can deliver large drug molecules into the skin or mucosa.
Geriene LaBine
Advertisement
Geriene LaBine, M. Sc., is head of quality control at Helix BioPharma.
Articles by Geriene LaBine
Advertisement
Latest Updated Articles
Stabilization of Interferon alpha-2b in a Topical CreamPublished: July 2nd 2009 | Updated:
Advertisement
Advertisement
